You are here

Metastatic Castration-Resistant Prostate Cancer Market - Growth Drivers Analysis and Business Trends Insights to 2030

Submitted by ashinde on Fri, 12/01/2023 - 02:47

The global metastatic Castration-Resistant Prostate Cancer market is expected to register a robust revenue CAGR over the forecast period owing to increased cases of prostate cancer. For instance, prostate cancer is the second most frequent cancer in males and fourth most prevalent cancer in general population. Among 343,089 individuals with prostate cancer, 3,690 cases of metastatic castration-resistant prostate (1.1%) were discovered. Prevalence rates of both total and metastatic castration-resistant prostate per-prostate cancer grew monotonically year-over-year between 2010 and 2017. Additionally, increasing prevalence of metastatic castration-resistant prostate, in turn, increases geriatric population, which is driving market growth.

Further, increased R&D activities, proposed new drug launch, increased prostate cancer diagnostic rate, technological advancement, increased healthcare expenditure, government support and reimbursement policies, significant increase in novel and innovative therapy, increased clinical trial for cancer drug, increased public awareness, increased geriatric population, change in lifestyle practices, increased sedentary life, unhealthy diet practice, increased prevalence of urological disorder in elderly population, are factors driving metastatic castration-resistant prostate market growth during the forecast period.

Request a sample report of Metastatic Castration-Resistant Prostate Cancer Market @

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

Novartis AG
Pfizer Inc.
Merck & Co., Inc.
Bayer AG
Clovis Oncology, Inc.
Astellas Pharma
Bristol-Myers Squibb Company
AbbVie Inc.
Hoffmann-La Roche Ltd.
Johnson & Johnson
Daiichi Sankyo Company Limited

Product Type Outlook (Revenue, USD Billion; 2019-2030)

Solid Dosage Form
Liquid Dosage Form

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

Parenteral Route

Treatment Outlook (Revenue, USD Billion; 2019-2030)

AR inhibitors
Targeted therapy
Docetaxel (for bone pain or other cancer-related symptoms)
Bone-modifying drug (to treat cancer that has spread to the bone)

Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

End-Use Outlook (Revenue, USD Billion; 2019-2030)


Read the full report @

Based on Region market is segmented into:

North America
South America
Middle East & Africa

Major Points covered in this report are as below:

An analysis of Metastatic Castration-Resistant Prostate Cancer industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
This report provides information on the market status of Metastatic Castration-Resistant Prostate Cancer manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Browse More Reports:

Deoxyribonucleic Acid (DNA) Testing Market @

Interventional Radiology Drainage Procedure Market @

Lead Acid Battery Scrap Market @

Urothelial Cancer Drug Market @

Vertical Injection Molding Machine Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370


Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @